- Home
- AKRO vs CLBT Comparison
AKRO vs CLBT Comparison
Compare AKRO & CLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CLBT
- Stock Information
- Founded
- AKRO 2017
- CLBT 1999
- Country
- AKRO United States
- CLBT Israel
- Employees
- AKRO N/A
- CLBT N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CLBT Computer Software: Prepackaged Software
- Sector
- AKRO Health Care
- CLBT Technology
- Exchange
- AKRO Nasdaq
- CLBT Nasdaq
- Market Cap
- AKRO 3.9B
- CLBT 4.1B
- IPO Year
- AKRO 2019
- CLBT N/A
- Fundamental
- Price
- AKRO $54.58
- CLBT $15.96
- Analyst Decision
- AKRO Strong Buy
- CLBT Strong Buy
- Analyst Count
- AKRO 6
- CLBT 7
- Target Price
- AKRO $82.50
- CLBT $22.43
- AVG Volume (30 Days)
- AKRO 1.8M
- CLBT 1.5M
- Earning Date
- AKRO 08-08-2025
- CLBT 08-14-2025
- Dividend Yield
- AKRO N/A
- CLBT N/A
- EPS Growth
- AKRO N/A
- CLBT N/A
- EPS
- AKRO N/A
- CLBT N/A
- Revenue
- AKRO N/A
- CLBT $419,170,000.00
- Revenue This Year
- AKRO N/A
- CLBT $20.75
- Revenue Next Year
- AKRO N/A
- CLBT $17.32
- P/E Ratio
- AKRO N/A
- CLBT N/A
- Revenue Growth
- AKRO N/A
- CLBT 22.04
- 52 Week Low
- AKRO $21.02
- CLBT $11.47
- 52 Week High
- AKRO $58.40
- CLBT $26.30
- Technical
- Relative Strength Index (RSI)
- AKRO 68.00
- CLBT 38.53
- Support Level
- AKRO $53.05
- CLBT $15.20
- Resistance Level
- AKRO $56.49
- CLBT $16.56
- Average True Range (ATR)
- AKRO 2.44
- CLBT 0.49
- MACD
- AKRO -0.26
- CLBT 0.09
- Stochastic Oscillator
- AKRO 86.02
- CLBT 37.97
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CLBT Cellebrite DI Ltd.
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.